Mitochondrial targeting of quinones: therapeutic implications.
about
Mitochondria-Targeted Antioxidants: Future Perspectives in Kidney Ischemia Reperfusion InjuryInnovative Target Therapies Are Able to Block the Inflammation Associated with Dysfunction of the Cholesterol Biosynthesis PathwayTargeting the redox balance in inflammatory skin conditionsInactivation of the ferroptosis regulator Gpx4 triggers acute renal failure in miceMechanistic evaluation of a novel small molecule targeting mitochondria in pancreatic cancer cellsMitochondrial dysfunction in inherited renal disease and acute kidney injuryThe role of mitochondria in reactive oxygen species metabolism and signaling.Mitochondrial oxidative stress and mammalian healthspan.The antioxidant transcription factor Nrf2 negatively regulates autophagy and growth arrest induced by the anticancer redox agent mitoquinoneThe mitochondria-targeted antioxidants and remote kidney preconditioning ameliorate brain damage through kidney-to-brain cross-talk.A mitocentric view of Alzheimer's disease suggests multi-faceted treatmentsMolecular strategies for targeting antioxidants to mitochondria: therapeutic implications.Mitochondrial medicine for aging and neurodegenerative diseasesMitochondrial dysfunction and oxidative stress in the pathogenesis of alcohol- and obesity-induced fatty liver diseases.Selective Mitochondrial Targeting Exerts Anxiolytic Effects In Vivo.Mechanical stress and ATP synthesis are coupled by mitochondrial oxidants in articular cartilageHow can we treat mitochondrial encephalomyopathies? Approaches to therapyRedox regulation of mitochondrial function with emphasis on cysteine oxidation reactions.Mitochondrial therapies for Parkinson's disease.Responsive hetero-organelle partition conferred fluorogenic sensing of mitochondrial depolarization.Therapeutic use of coenzyme Q10 and coenzyme Q10-related compounds and formulations.Antioxidant approaches for the treatment of Alzheimer's disease.Current and emerging treatment options in the management of Friedreich ataxia.Polyphenols and human health: a prospectus.Less than perfect divorces: dysregulated mitochondrial fission and neurodegeneration.Drugs and mitochondrial diseases: 40 queries and answers.Enhanced production techniques, properties and uses of coenzyme Q10.Vitamin B12 protects against superoxide-induced cell injury in human aortic endothelial cells.Pathophysiological implications of mitochondrial oxidative stress mediated by mitochondriotropic agents and polyamines: the role of tyrosine phosphorylation.In Vitro Antioxidant Activity of Idebenone Derivative-Loaded Solid Lipid Nanoparticles.Mitochondrial delivery of doxorubicin by triphenylphosphonium-functionalized hyperbranched nanocarriers results in rapid and severe cytotoxicity.Mitochondrial biotransformation of omega-(phenoxy)alkanoic acids, 3-(phenoxy)acrylic acids, and omega-(1-methyl-1H-imidazol-2-ylthio)alkanoic acids: a prodrug strategy for targeting cytoprotective antioxidants to mitochondria.Identification of transcriptional networks responding to pyrroloquinoline quinone dietary supplementation and their influence on thioredoxin expression, and the JAK/STAT and MAPK pathways.Mitochondria-targeted ubiquinone (MitoQ) decreases ethanol-dependent micro and macro hepatosteatosis.Specific inhibition of mitochondrial oxidative stress suppresses inflammation and improves cardiac function in a rat pneumonia-related sepsis model.Mitochondria-targeted antioxidant (MitoQ) ameliorates age-related arterial endothelial dysfunction in mice.Mitochondria-targeted Probes for Imaging Protein Sulfenylation.ALSUntangled No. 29: MitoQ
P2860
Q26744639-DD38F380-0BEE-4CE7-B241-7FD1A8A09646Q26771260-0A9007E4-327D-4111-BD4D-2C5B00B87F77Q27023252-6F09FE49-2A72-4DE4-9390-52E3531AC54FQ28396141-9CF33B8E-FD63-4B61-916E-E4E30AC7726EQ28485201-D04872E8-9C13-4F8E-A327-CA1EDC3D30A8Q33793389-E0BBBD3C-1831-47A0-B39A-A91D59AEDA3EQ33849198-99D10FC3-CE27-4F84-83B6-1F63BFC7AB70Q34104004-CAB4186B-6E4B-424A-9DBE-808261F4AC10Q34251106-48CA6733-ABAF-4F38-92C3-8B6D16509826Q34525337-5456F63A-4C4A-43CF-BFC8-D1EC600DB63DQ34902708-6AA3C1F0-29F8-4921-9821-FE0F68BA0926Q35148462-E17F39FC-C54A-4870-A587-1213D9965787Q35606693-015824A2-8B1F-48D4-B2C3-60EEA97FA36AQ36572087-3DFB589D-B4BA-4121-AEB3-4A76841C9A1BQ36906640-FC94224A-C646-4561-AD4A-A8F88DE403B1Q36917888-2B0B4DC1-5A75-4540-A18A-EFD7CF7990E7Q37329530-567DA6E2-AD26-4689-8EA0-C42BC1583C0EQ37493001-55568706-FDEA-441C-89B3-4F77B304BDDCQ37699222-4616EA93-C8AB-4838-B987-C1697796AB40Q37719655-70B7F4C3-769D-4460-8FCA-CA906649C39BQ37724200-4EDCA1ED-919C-40D6-AD85-AC052EEA8289Q37768449-0BA4BD5B-EC46-4073-A046-577ADFD93CB6Q37790615-8440E516-A194-4AC3-9FC1-3B75CCE72CE8Q37934984-30D42F67-3D86-4840-A565-6921185C30F1Q37969636-A35C858A-DCAE-4441-A274-35CC3ED2A48DQ37980195-EE1B1929-0C37-45B6-99C0-61223A3B40C4Q38232408-713424DE-4083-4F4A-8CF7-08169BB7E857Q38267437-983E3088-6ABA-4ACC-A39E-18EE7A12624DQ38384633-7CD66D6F-71F9-4308-B6A4-5DBE135872F8Q38758042-5FC6C54E-39F2-4C82-80FE-F6A37B22B825Q39114419-D92D31AB-4FE8-4B79-AD3F-8307120005CCQ41126212-8709DDA2-FFBC-425A-BA49-2C2A063931B5Q41931606-99DAB79B-DA7D-4247-83EF-BAB15C5125ADQ42171502-1F671106-B952-4DC7-BF4A-B581C9A55584Q44290150-9D40C62D-2CDB-45F5-98DF-8AD85346DC1BQ51746246-09E2C72B-C59F-4ECE-85B6-F3B1C2CA75D8Q55114069-854625BC-DFEE-459B-B7C8-954E88275960Q57464297-A6F58228-0517-48B3-BE52-7A76A43F8313
P2860
Mitochondrial targeting of quinones: therapeutic implications.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Mitochondrial targeting of quinones: therapeutic implications.
@en
type
label
Mitochondrial targeting of quinones: therapeutic implications.
@en
prefLabel
Mitochondrial targeting of quinones: therapeutic implications.
@en
P2093
P1433
P1476
Mitochondrial targeting of quinones: therapeutic implications
@en
P2093
Abdul-Rahman B Manas
Andrew M James
Carolyn M Porteous
Frances H Blaikie
Geoffrey F Kelso
Helena M Cochemé
Jordi Asin-Cayuela
Meredith F Ross
Robin A J Smith
Thabo Mahendiran
P304
P356
10.1016/J.MITO.2007.02.007
P478
P577
2007-03-16T00:00:00Z